OEC and the Promise of Therapeutic Imaging
Executive SummaryIn a land of multi-modality imaging giants, OEC has more than held its own with a highly focused niche strategy. Advances in minimally-invasive surgery should further boost OEC, which offers surgeons a different kind of visualization solution. Now OEC has to convince investors of the value of steady, if unspectacular, growth.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.